OLIGONUCLEOTIDES MEDICAL THERAPEUTIC PURPOSES

Brand Owner Address Description
STOPS Aligos Therapeutics, Inc. 1 Corporate Drive, 2nd Floor South San Francisco CA 94080 Oligonucleotides for medical therapeutic purposes; nucleic acids for medical therapeutic purposes; pharmaceutical preparations, namely, antivirals; pharmaceutical preparations, namely, oligonucleotides and polymers that control viral replication; oligonucleotide and polymer preparations for therapeutic pharmaceutical purposes in the treatment of viral diseases; nucleic acid polymers for therapeutic medical use;Oligonucleotide and polymer ingredients for use in the manufacture of pharmaceutical preparations in the nature of antiviral drugs;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. An improved delivery system for antisense oligonucleotides involves a liposomal composition, comprising a liposome which consists essentially of neutral phospholipids and an antisense oligonucleotide that is entrapped in the liposome and is selected from the group consisting of phosphodiester oligonucleotides, phosphorothioate oligonucleotides, and p-ethoxy oligonucleotides.